Withings acquires Impeto Medical

Share on facebook
Share on twitter
Share on linkedin

Press release:
Withings acquires Impeto Medical

Impeto Medical is a French company created in 2005  specializing in the research, development, production and sales of innovative medical devices, especially in the field of detection and monitoring of peripheral neuropathies.

With more than thousands of Sudoscan products sold worldwide, Impeto Medical sets a new standard in the field of detection and monitoring of small fiber neuropathies from the doctor’s office, particularly important for the prevention of serious complications such as diabetes and several neurological diseases. As of November 20, 2021, Impeto Medical’s activities have been completely sold to Withings company.

Founded in 2008, Withings is the European connected health leader. Composed of teams of engineers, data science experts and health professionals, Withings invents, designs, and manufactures a range of award-winning, clinically validated smart health devices and associated apps. Used by millions of users worldwide, Withings smartwatches, blood pressure monitors, sleep trackers and connected scales empower everyone to take control of their health, prevent, detect and monitor underdiagnosed chronic conditions.

The sale of Impeto Medical to Withings constitutes a major opportunity to continue supporting
the development of Sudoscan technology, whether in France or internationally.
Sudoscan is still being marketed normally in France and in other countries. The entire team remains at your service, whether it is sales, service, administration or support.

Impeto Medical

Impeto Medical

About SUDOSCAN

SUDOSCAN is a quick and non-invasive test that provides an accurate evaluation of sweat gland function reflecting the status of the autonomic nervous system.

With quantitative and reproducible results, SUDOSCAN allows physicians to detect early and follow-up peripheral neuropathy to monitor disease progression and assess treatment efficacy for better patient management.

SUDOSCAN efficacy has been evaluated in the assessment of small fiber neuropathies in several diseases and compared to reference tests recommended in guidelines.

Recent Posts

Subscribe to receive our scientific news

Name(Required)
Consent(Required)

Website dedicated
to health professionals

I am a health professional

To receive our latest scientific news:

Scroll to Top